Suggestive SNP-SNP interactions—secondary analysis.

SNP: single nucleotide polymorphism, Chr: chromosome; MAF: minor allele frequency; BHF-FHS: British Heart Foundation Family Heart Study; MIGen: Myocardial Infarction Genetics Consortium; SNPA Pvalue: level of nominal statistical significance for single marker association with coronary artery disease for SNP A; SNPB Pvalue: level of nominal statistical significance for single marker association with coronary artery disease for SNP B; Int. Pvalue BHF-FHS: interaction P value in BHF-FHS; Int. Pvalue MIGen: interaction P value in MIGen; N/A: replication not available. FRMD4B: FERM domain containing 4B; PLA2G4A: phospholipase A2, group IVA; FURIN: furin (paired basic amino acid cleaving enzyme); CUBN: cubilin (intrinsic factor-cobalamin receptor); KLK1: kallikrein 1; PRKCQ protein kinase C, theta; SBDS: Shwachman-Bodian-Diamond syndrome; NCAM1: neural cell adhesion molecule 1; RARB: retinoic acid receptor, beta; PDE7A: phosphodiesterase 7A; SFTPD: surfactant protein D; LDLRAP1: low density lipoprotein receptor adaptor protein 1; BCL9: B-cell CLL/lymphoma 9; TGFBR2: transforming growth factor, beta receptor II (70/80kDa); TIMP3: TIMP metallopeptidase inhibitor 3; HMGCS2: 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial); PDE4B: phosphodiesterase 4B, cAMP-specific.Suggestive SNP-SNP interactions—secondary analysis.